|
|
Volumn 32, Issue 7, 2001, Pages 1090-1094
|
|
Effect of highly active antiretroviral therapy on the serological response to additional measles vaccinations in human immunodeficiency virus-infected children
c
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIRETROVIRUS AGENT;
ANTIVIRUS AGENT;
DIDANOSINE;
IMMUNOGLOBULIN G;
LAMIVUDINE;
MEASLES MUMPS RUBELLA VACCINE;
NELFINAVIR;
NEVIRAPINE;
RITONAVIR;
STAVUDINE;
ZIDOVUDINE;
ANTIBODY RESPONSE;
ARTICLE;
CHILD;
CHILDHOOD DISEASE;
CLINICAL ARTICLE;
CONTROLLED STUDY;
DRUG EFFICACY;
FEMALE;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
IMMUNE SYSTEM;
MALE;
MEASLES;
MEASLES VACCINATION;
PRIORITY JOURNAL;
REVACCINATION;
TREATMENT OUTCOME;
VACCINATION;
VIRUS INFECTION;
ANTIBODIES, VIRAL;
ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE;
CD4 LYMPHOCYTE COUNT;
CHILD;
FEMALE;
HIV INFECTIONS;
HUMANS;
MALE;
MEASLES VIRUS;
MEASLES-MUMPS-RUBELLA VACCINE;
VACCINATION;
VIRAL LOAD;
|
|
EID: 0035310504
PISSN: 10584838
EISSN: None
Source Type: Journal
DOI: 10.1086/319591 Document Type: Article |
|
Times cited : (64)
|
|
References (11)
|
